1.20BMarket Cap-12.24P/E (TTM)
18.260High17.680Low251.55KVolume18.150Open18.160Pre Close4.52MTurnover0.38%Turnover RatioLossP/E (Static)66.47MShares53.69052wk High4.55P/B1.19BFloat Cap17.64052wk Low--Dividend TTM65.88MShs Float302.500Historical High--Div YieldTTM3.19%Amplitude2.140Historical Low17.959Avg Price1Lot Size
Tandem Diabetes Care Stock Forum
anyone having any idea why share price dropped like crazy after such a good performance result? especially FDA clearance for type 2 just been received? doesn’t make sense isn’t it?
Tandem's Automated Insulin Technology Breaks New Ground: FDA Approves for Type 2 Diabetes
-- Worldwide GAAP sales increased 13 percent to $221.9 million compared to
second quarter 2023; worldwide non-GAAP sales(1) increased 12 percent to
$221.8 million compared to second quarter 2023.
-- More than 20,000 pumps shipped in the United States, a sequential
increase of 33 percent compared to first quarter 2024.
-- Launched Tandem Mobi with Dexcom G7 continuous glucose monitoring (CGM)
sensor integration in th...
Just check call options. they are expensive
However, stock price moves only 5-10% with no news. Something is going on behind the scene?!
No comment yet